NCI renews ‘comprehensive’ designation for cancer center
The National Cancer Institute once again recognized UC Davis Comprehensive Cancer Center as one of the nation’s most elite, renewing its “comprehensive” designation in recognition of its breadth and depth in research, care, cancer control and population sciences. The UC Davis center is one of only 51 in the nation with the designation, and is the only NCI-designated center outside of San Francisco from the Bay Area to Portland and Salt Lake City, with more than 100,000 patients visiting annually.
Changes needed in cancer care for teens and young adults
Pediatric oncologist Elysia Alvarez, M.D., M.P.H., is advocating for changes in how care is provided for adolescent and young adult (AYA) cancer patients after leading a global study that looked at the burden of cancer on AYAs. Published in The Lancet Oncology, the research shows that AYA patients have unique physical and emotional needs, and there are disparities to accessing treatment and outcomes in this age group. The findings shine a light on the need to develop a new approach to global cancer control from childhood to adulthood.
New guidebook to address HPV vaccine hesitancy
The UC Davis Comprehensive Cancer Center has joined the Center for Health Law and Policy Innovation of Harvard Law School to create a new resource called the HPV Vaccine Policy Landscape, Public Health Strategies. The new guidebook highlights the roles that state policy makers, educational institutions, and health care providers can play in increasing HPV vaccination rates by navigating the policy landscape more effectively.
